Adamax
Next-Generation Semax Derivative | Nootropic Neuropeptide
On this page
What is Adamax?
Adamax is a lab-made peptide built from Semax, a well-studied nootropic compound, with extra chemical modifications designed to help it cross into brain tissue more easily. Early laboratory research looks at how it interacts with brain-signaling proteins like BDNF, in animal and cell-culture studies rather than large human trials. It's sold here strictly as a research chemical for laboratory study, not for use in people or animals.
Key terms:
Adamax is a synthetic modified heptapeptide derivative.
Adamax is a lab-made peptide built from Semax, a nootropic (a compound studied for memory and focus). Chemists added an acetyl group at one end and an adamantane group at the other, making it more stable and better at crossing the blood-brain barrier (the filter that protects the brain). Researchers study it for cognitive effects, nerve protection, neuroplasticity (the brain forming new connections), and early work on stroke recovery and mood.
Key research areas
- Enhanced cognitive function
- Improved focus and mental clarity
- Neuroprotection
- Neuroplasticity support
- Potential mood enhancement
- Stress resilience
- Studied bioavailability improvements through direct systemic delivery
Researched dosing
This table reflects how researchers and the community have structured Adamax study protocols — dose ranges and schedules presented as research-methodology reference, not usage instructions.
| Phase | Dose | Frequency | Route |
|---|---|---|---|
| Cognitive-performance studies | 200-300mcg | 1x daily | SubQ |
| Neuroprotection models | 300mcg | 1-2x daily | SubQ |
| Mood studies | 200mcg | 1x daily (morning) | SubQ |
| Initial assessment | 100-200mcg | 1x daily | SubQ |
Commonly cycled 4 weeks on, 2+ weeks off.
How it works
At the cell level, Adamax research looks at how the peptide's chemical modifications help it reach brain tissue and interact with signaling proteins like BDNF — the terms below describe those same cell-signaling steps.
Adamax crosses the blood-brain barrier via enhanced lipophilicity from adamantane modification. It upregulates BDNF and TrkB receptor sensitivity, modulates dopamine, norepinephrine, and serotonin levels, stabilizes microtubules through ADNP-derived mechanisms, and provides antioxidant and anti-inflammatory neuroprotection.
Molecular data
These figures — molecular weight, chain length, sequence — are the chemistry ID researchers use to confirm an Adamax sample's identity and its added adamantane modification compared to its parent compound, Semax.
- Weight
- 1032.24 Da
- Length
- 9 amino acids
- Type
- Modified heptapeptide derivative
Ac-Met-Glu-His-Phe-Pro-Gly-Pro-AGly-NH2
Research applications
This section summarizes the research areas — cognitive, neuroprotective, and mood-related pathways — that early studies and anecdotal reports have looked at for Adamax; it's a summary of what's been studied, not medical claims about people, and human research on Adamax specifically remains limited.
Cognitive
Anecdotal reports and preliminary research suggest improvements in focus, mental clarity, memory consolidation, and ability to handle complex cognitive tasks without overwhelm. BDNF upregulation and TrkB receptor enhancement promote formation of new neural connections, synaptic plasticity, and long-term cognitive improvements through structural brain changes. Based on parent compound research, Adamax may enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.
Neuroprotective
Neuroprotective effects through antioxidant and anti-inflammatory mechanisms, microtubule stabilization via ADNP-derived pathways.
Mood
Modulation of dopamine, norepinephrine, and serotonin levels contributing to potential mood enhancement and reduced anxiety.
Dosage reference
- Doses used in research
- 200–300 mcg
- Frequency in studies
- 1x daily
- Handling
- Reconstituted solution — research use only; not for administration
- Timeline reported in studies
- Hours for acute effects, 2-4 weeks for neuroplasticity
- Storage
- Fridge 2-8°C, use within 14-30 days
- Cycle length
- 2-4 weeks
- Break between cycles
- 2-4 weeks to prevent tolerance
Interactions
This list shows which other nootropic peptides are studied or used alongside Adamax, and why.
Reconstitution & storage
This is the standard laboratory method for turning freeze-dried Adamax powder into a liquid research solution using bacteriostatic water.
- Clean work area and hands thoroughly with alcohol
- Calculate required BAC water volume using calculator below
- Draw calculated BAC water into syringe
- Inject slowly down vial side (not directly onto powder)
- Gently swirl until completely dissolved (never shake vigorously)
- Store the reconstituted solution refrigerated (2–8°C), labeled with the date and concentration, for laboratory research use only.
Lyophilized: Cool, dry place (room temperature), use within Per manufacturer expiration date
Reconstituted: 2-6°C, use within 14-30 days
Open the Adamax reconstitution calculatorQuality indicators
These are the visual checks — powder appearance, solution clarity — researchers use to confirm an Adamax sample hasn't degraded before it goes into a study.
White, Fluffy Powder - Lyophilized Adamax should appear as white to off-white, fluffy powder filling the vial bottom. Indicates proper freeze-drying and storage.
Clear Solution After Reconstitution - When properly mixed with BAC water, solution should be crystal clear with no particles, cloudiness, or discoloration.
Proper Labeling - Vial should have clear labeling with peptide name, batch number, manufacturing date, and storage instructions from reputable research supplier.
Slight Compaction - Minor compaction from shipping is acceptable if powder dissolves completely with gentle swirling. Should not remain permanently clumped.
Discoloration or Yellowing - Any yellow, brown, or unusual coloration indicates oxidation, degradation, or improper storage. Adamax should be white to off-white only.
Cloudy After Reconstitution - Persistent cloudiness, particles, or precipitates after gentle mixing indicate degraded, contaminated, or improperly manufactured peptide.
What to expect
This timeline summarizes what preliminary research and anecdotal reports describe at each stage — research context for comparing observations, not a personal-results promise.
Potential acute cognitive enhancement and improved focus
Enhanced mental clarity, reduced anxiety, improved mood
Neuroplasticity benefits, sustained cognitive improvements
Maximum neuroprotective and structural brain benefits
Safety notes
This section covers handling cautions for Adamax — it's an experimental peptide with limited human research data, and this is research-use-only scope, not medical advice.
- Not recommended during pregnancy or breastfeeding
- Consult healthcare provider before use, especially with cardiovascular conditions
- CRITICAL: This is an experimental peptide with limited human research data
Regulatory status
- Not approved by the FDA for any indication.
- Supplied and described for laboratory research use only — not for human or veterinary use.
Community data
Community Insights
Based on data the community reported. Not clinical proof.
References
Preliminary clinical observations indicate patients treated with Adamax shortly after stroke had better neurological outcomes compared to control groups, potentially through reduction of oxidative stress and neuronal repair mechanisms.
Research demonstrates Adamax increases Brain-Derived Neurotrophic Factor (BDNF) levels and enhances TrkB receptor sensitivity in the hippocampus, fundamental mechanisms for neuroplasticity and cognitive enhancement.
Research indicates Adamax influences levels of dopamine, norepinephrine, and serotonin, contributing to improved mood, reduced anxiety, and enhanced cognitive function through balanced neurotransmitter activity.